Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;33(4):e13535.
doi: 10.1111/dth.13535. Epub 2020 May 20.

Effects of 5-alpha reductase inhibitors on lung function: A reason for discontinuation during COVID-19 pandemic?

Affiliations
Comment

Effects of 5-alpha reductase inhibitors on lung function: A reason for discontinuation during COVID-19 pandemic?

George Kroumpouzos. Dermatol Ther. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Comment on

References

    1. Goren A, McCoy J, Wambier CG, et al. What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy. Dermatol Ther. 2020;33(4):e13365. 10.1111/dth.13365. - DOI - PMC - PubMed
    1. Mikkonen L, Pihlajamaa P, Sahu B, Zhang FP, Jänne OA. Androgen receptor and androgen‐dependent gene expression in lung. Mol Cell Endocrinol. 2010;317(1–2):14‐24. - PubMed
    1. Qiu Y, Zhao Y‐B, Wang Q, et al. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS‐CoV‐2. Microbes Infect. 2020. 10.1016/j.micinf.2020.03.003. - DOI - PMC - PubMed
    1. Dhurat R, Sharma A, Rudnicka L, et al. 5‐alpha reductase inhibitors in androgenetic alopecia: shifting paradigms, current concepts, and comparative efficacy and safety. Dermatol Ther. 2020;e13379. 10.1111/dth.13379 [Epub ahead of print]. - DOI - PubMed
    1. Azzouni F, Godoy A, Li Y, Mohler J. The 5 alpha‐reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol. 2012;2012:530121. 10.1155/2012/530121. - DOI - PMC - PubMed

Substances